NCT00907985 - A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 15, 2009

Primary Completion Date

June 10, 2010

Study Completion Date

June 10, 2010

Conditions

Bipolar Disorder

Interventions

DRUG

Placebo

Single dose of placebo will be provided.

DRUG

Vofopitant

Vofopitant (GR205171) will be provided as 5 milligram single dose capsule administered orally. It will be available as swedish orange, size 0 capsules.

DRUG

Lamotrigine

Lamotrigine will be provided as 25 milligrams or 100 milligrams single dose dispersible tablet administered orally.

Trial Locations (1)

37075

GSK Investigational Site, Göttingen